Respiratory Testing Solution

A fully-automated approach to respiratory testing.

Multiple assay boxes in lab background

Simplify & Scale Your Testing Capacity

Readiness for the respiratory viral season is a priority for every lab. As COVID-19 shifts from pandemic to endemic, accurate and timely detection and differentiation of viruses with flu-like symptoms will be crucial to guide patient care and assist infection control.

To help you simplify and scale testing capacity, the Hologic Molecular Scalable Solutions respiratory portfolio now offers multiplex capabilities, including for SARS-CoV-2. The new Panther® Fusion assay, covering Flu A, Flu B, RSV and SARS-CoV-2, enables high volume testing at scale of the most common respiratory viruses, helping you diagnose and deliver results sooner.1

Resilience to Cope With Seasonal Surges

We have built up our expertise in developing high-performing assays in the response to the unparalleled demands of SARS-CoV-2. 

We help labs build first-class diagnostic capability and capacity, to meet seasonal demands and emerging global threats.

When demand peaks, you need a solution that you can trust and that deliver results.

Flexibility to do More With Less

We offer a fully automated, modular approach to syndromic respiratory testing, enabling you to target the right patient with the right test.

Our respiratory solution allows you to act quickly and at scale, with greater flexibility.

High throughput testing is available for the most common respiratory infections.

Boosting Workflow Efficiency & Clinical Insight

We continually invest in research and development to improve our portfolio to help meet your needs.

Our latest assay combines four targets in one high-performance assay, Flu A, Flu B, RSV and SARS-CoV-2. 1

The Panther® Fusion assay lets you test a single specimen from a patient who may have overlapping symptoms.1

Personalised Patient Testing2

Personalised patient testing enables accurate and timely diagnosis.

True random access and STAT applications offer workflow efficiency, allowing samples to be continuously loaded without the need to batch to perform multiple test orders.

This help you to prioritise urgent patients without impacting wider testing workflow.

Combining High Assay Performance with Automation

One sample and multiple testing capability depending on clinical needs gives you a modular approach for syndromic, respiratory testing.

2 Tiers

of automation with Panther and Panther Fusion providing scalable support.

13 Targets

our family of assays targets multiple respiratory viruses and two Bordetella species.

1 New

assay covering Flu A, Flu B, RSV and SARS-CoV-2.

Explore the Respiratory Testing Solution

Insights

Mother comforting her young daughter, sitting on a couch with laptop showing a doctor on the screen.

Molecular Testing Transforms Acute Gastroenteritis Diagnostics

Cervical screening infographics

Discover the Future of Cervical Cancer Screening

A scientist is carefully pouring liquid from a bottle into a container in a laboratory setting.

Navigating Respiratory Demands with Molecular Precision

    1. Panther Fusion SARS-CoV-2/FluA/B/RSV assay [package insert]. AW-25328-001 Rev. 003. San Diego, CA: Hologic, Inc.; 2026
    2. Panther/Panther Fusion System Operator's Manual AW-30520-001 Rev. 001 (EN) San Diego, CA: Hologic Inc.; 2024
    3. Panther Fusion Flu A/B/RSV assay [package insert]. AW-23081-001 Rev. 002. San Diego, CA: Hologic, Inc.; 2026
    4. Panther Fusion AdV/hMPV/RV assay [package insert]. AW-29005-001 Rev. 001. San Diego, CA: Hologic, Inc.; 2023
    5. Panther Fusion Paraflu assay [package insert]. AW-23708-001. Rev 001. San Diego, CA: Hologic, Inc.; 2022
    6. Panther Fusion Bordetella assay [package insert]. AW-18637-001 Rev. 002. San Diego, CA: Hologic, Inc.; 2024
     

    Related Portfolios & Solutions

    Lab technician in white coat carrying test tubes
    Portfolio

    Molecular Scalable Solution

    A scalable portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population level screening.

    Multiple Thinprep vials on rack
    Portfolio

    Cervical Health

    We pride ourselves on being champions of women’s health and global leaders in screening. From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive and unique screening portfolio, from sample collection to diagnosis.

    Solution

    High-Throughput Testing

    Solution

    Gastrointestinal

    Solution

    STI

    Solution

    Virology

    Solution

    Transplant

    Solution

    HPV

    Solution

    Vaginal Health

    Solution

    Hospital Acquired Infections

    Solution

    Lab Developed Tests

    Solution

    Collection Devices

    2797

    Hologic BVBA Da Vincilaan 5 1930 Zaventem Belgium

    Notified Body number wherever applicable

    EC Rep details wherever applicable